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Purpose: Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) as well as the 
respective amino-terminal NT-proANP and NT-proBNP have now been well established as 
predictors of outcome in patients with heart failure (HF). C-type natriuretic peptide (CNP) and NT-
proCNP are increased in HF patients as a function of disease severity, supporting a role for these 
peptides in the pathophysiology of HF, but their modifications during left ventricular assist device 
(LVAD) implant are lacking. Aim of this study was to evaluate the time-course of natriuretic 
peptides in end-stage HF patients undergoing LVAD implant in order to recognize new reliable 
predictive biomakers of cardiac recovery during LVAD. 
Methods: Five end-stage HF patients (NYHA class III and IV; age: 57±11 yrs; LVEF%<20) 
undergoing LVAD implantation were studied. Clinical hemodynamic evaluation and blood samples 
were obtained at admission (T1) and at 4, 24, 72 hrs and 1, 2, 4 weeks (T2-T7) after LVAD implant. 
NT-proANP and NT-proCNP were measured in plasma EDTA and aprotinin samples by a direct 
ELISA () while NT-proBNP by the Elecsys® 2010 analyzer. 
Results: The NT-proCNP time-course during LVAD was the following: T1=88.8±12.8 pg/ml; 
T2=144±29.8; T3=241.6±86.8 (p<0.05 vs T1); T4=229.7±66.4; T5=162.3±66.5; T6=175.3±47.7; 
T7=76.9±8 (p=ns vs T1). NT-proANP showed a similar pathway while NT-proBNP is reduced after 
LVAD implant (T1=4.1±2.2 ng/ml; T3=3.0±0.4), remaining lower than at baseline until 4 weeks 
(T7=3.1±0.9 ng/ml). NT-proCNP positively correlated with NT-proANP (p=0.03) while no 
correlation was found with NT-proBNP. 
Conclusions: This study reports for the first time original data on NT-proCNP levels after LVAD 
as a function of the time. The natriuretic peptides are differently modulated by LVAD, although all 
peptides resulted reduced after 4 weeks from implantation. The parallel determination of these 
effectors could allow us to obtain an integrated description of pathophysiological changes occurring 
during mechanical support. 
 
 
